Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions

The HER2/neu oncogene encodes a receptor-like tyrosine kinase whose overexpression in breast cancer predicts poor prognosis and resistance to conventional therapies. However, the mechanisms underlying aggressiveness of HER2 (human epidermal growth factor receptor 2)-overexpressing tumors remain inco...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pradeep, C-R, Zeisel, A, Köstler, WJ, Lauriola, M, Jacob-Hirsch, J, Haibe-Kains, B, Amariglio, N, Ben-Chetrit, N, Emde, A, Solomonov, I, Neufeld, G, Piccart, M, Sagi, I, Sotiriou, C, Rechavi, G, Domany, E, Desmedt, C, Yarden, Y
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616212/
https://ncbi.nlm.nih.gov/pubmed/22139081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.547
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak